Treatment of nasal hemangiomas

Simić, Radoje; Vlahovic, Aleksandar M.; Subarevic, Vladan

doi:10.1016/j.ijporl.2009.07.002

Cited by 27 publications

(31 citation statements)

References 20 publications

(52 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The treatment choices of nasal hemangiomas are still controversial considering use of preoperative medical treatment, timing of surgery, surgical approach and necessity of skin resection [15,27]. Pharmacological, surgical or laser interventions are current treatment options for nasal hemangiomas [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27]. A "no-touch" or conservative approach for the treatment of nasal hemangiomas was previously advocated with frequent consultations with the parents to furnish psychological support [26].…”

Section: Treatment Optionsmentioning

confidence: 99%

“…Although subglottic hemangiomas are rare, they are extremely dangerous due to their location and rapid growth during the proliferative phase. "Beard" distribution of hemangioma is highly suspected for subglottic localization of hemangioma [5,6,23]. Most IHs are small, harmless tumors that should be allowed to involute without treatment.…”

mentioning

confidence: 99%

“…The management of hemangioma is an area of great controversy [6]. Current options are conservative treatment (corticosteroids, interferons, hemiotherapy, propranolol), laser treatment, and surgical treatment [6,[9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27]. Corticosteroids were generally accepted to be the first-line therapy for hemangiomas [6].…”

mentioning

confidence: 99%

“…Recently propranolol proved itself effective in inducing regression of growing hemangioma. There are several reports confirming prompt response of hemangioma to propranolol with no major side effects [23,25,28,29]. There are three questions regarding surgical intervention: 1) what are the indications, 2) when it should be done (timing) and 3) how it should be done [30].…”

mentioning

confidence: 99%

“…There is a need for particular attention to hemodynamic consideration with anesthesia and potential need for transfusion. Haemostatic squeezing suture around the hemangioma can be used prior to resection to avoid blood loss [23].…”

mentioning

confidence: 99%

See 4 more Smart Citations

Surgical Management of Nasal Hemangiomas

Vlahovic¹

2011

Rhinoplasty

View full text Add to dashboard Cite

Section: Treatment Optionsmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Surgical Management of Nasal Hemangiomas

Vlahovic¹

2011

Rhinoplasty

View full text Add to dashboard Cite

Modern Management of Nasal Hemangiomas

Keller

Stevens

Hochman³

2017

JAMA Facial Plast Surg

View full text Add to dashboard Cite

here is a wealth of literature dedicated to the pathogenesis, diagnosis, and clinical behavior of infantile hemangiomas (IHs), which are the most common benign tumors of infancy. Therapeutic strategies, however, are less well studied, and continue to evolve as laser, surgical, and medical interventions are refined to attain the best cosmetic and functional outcomes. Infantile hemangiomas of the nose (IHNs) comprise a special subset of these tumors owing to their effect on a structure with known functional, aesthetic, and psychosocial importance. Because of the relatively low incidence of IHNs, the timing, type, duration, and extent of treatment are topics of debate. Recently, a more aggressive approach for a wider range of tumors has been gaining strength because of the excellent efficacy and safety profile of β-blockers and the availability of a US Food and Drug Administration-approved formulation for infants with IHs. [1][2][3] The paucity of outcomes data for management of IHN, however, makes planning of generalized treatment difficult. Because of this difficulty, we hypothesized that a standardized therapeutic protocol for IHNs that is capable of achieving acceptable aesthetic and functional outcomes by 2.5 to 3 years of age (when a sense of self begins to form) could be developed from consensus literature reports and personal experience. 1,4 To address this hypothesis, we performed a retrospective record review of treatment approaches and outcomes in our patient population and compared this experience with that in the literature. Methods Primary StudyWe performed a retrospective review of all patients with IHNs treated by a single surgeon (M.H.) in a tertiary referral private practice between January 1, 1999, and December 31, 2015. Inclusion criteria were diagnosis of IHN, documentation of medical and/or surgical interventions, and duration of follow-up of 1 year or more. Patients were excluded if management consisted solely of observation for tumors or anomalies other than IHNs and if the IHN was confined solely to the glabella. Patient records were mined for demographic data, tumor-specific variables, clinical data, therapeutic interventions, and outcomes. Tumor-specific variables were as follows: (1) depth of involvement, characterized as superficial lesions extending to the dermis only, deep lesions confined to the subcutaneous or subdermal tissue, and compound lesions with simultaneous superficial and deep components; (2) tumor distribution, characterized as focal tumors involved in solitary nasal subunits and segmental tumors involved in multifocal and/or dermatomal distributions; and (3) tumor life IMPORTANCE Current treatment approaches for infantile hemangiomas of the nose include observation, pharmacologic agents, surgery, and/or laser therapy. Because of the known functional, social, and cosmetic effect of nasal deformities, obtaining the best possible result is critical. Optimal timing, type, duration, and extent of therapy remain unclear.OBSERVATIONS Results of a review of 86 patients (64 female...

show abstract